Preferred
(EDT)
LRAs and Immunomodulatory Agents
10:35 AM - 12:35 PM EDT
Wednesday, June 2, 2021Room: V100 - Ben Schramm Other
LRAs and Immunomodulatory Agents
Immune-Based Strategies for HIV Cure
10:35 AM - 11:00 AM EDT
Wednesday, June 2, 2021Room: V100 - Ben Schramm Speaker
Devi SenGupta, MD
Gilead Sciences, Inc.
LRAs and Immunomodulatory Agents
Controlling HIV Rebound in Humanized Mice
11:00 AM - 11:25 AM EDT
Wednesday, June 2, 2021Room: V100 - Ben Schramm Speaker
Jerome Zack, PhD
University of California, Los Angeles
LRAs and Immunomodulatory Agents
SMYD Methyltransferases are Versatile Regulators of HIV Transcription
11:25 AM - 11:50 AM EDT
Wednesday, June 2, 2021Room: V100 - Ben Schramm Speaker
Melanie Ott, MD
Gladstone Institutes
LRAs and Immunomodulatory Agents
Short Talk: Reduction of HIV Reservoirs in CD4+ T Cells from Well-Suppressed HIV+ Participants by Autologous Expanded NK Cells
11:50 AM - 12:05 PM EDT
Wednesday, June 2, 2021Room: V100 - Ben Schramm Speaker
Mary Ann Checkley, PhD
Case Western Reserve University
LRAs and Immunomodulatory Agents
Short Talk: Modulating HIV-1 Envelope Glycoprotein Conformation to Decrease the HIV-1 Reservoir
12:05 PM - 12:20 PM EDT
Wednesday, June 2, 2021Room: V100 - Ben Schramm Speaker
Jonathan Richard, PhD
Centre de Recherche du CHUM
LRAs and Immunomodulatory Agents
Short Talk: bNAb Administration Spanning ATI Does Not Alter the Endogenous Env-specific Humoral Response in SIV-infected Macaques
12:20 PM - 12:35 PM EDT
Wednesday, June 2, 2021Room: V100 - Ben Schramm Speaker
Hannah King, PhD
U.S. Military HIV Research Program, Walter Reed Army Institute of Research
LRAs and Immunomodulatory Agents
